The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

Drug Intelligence & Clinical Pharmacy: Vol. 22, No. 12, pp. 946-952.
© 1988 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, D.
Right arrow Articles by Thompson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, D.
Right arrow Articles by Thompson, G.

Research Articles

Fibrin glue: a review of its preparation, efficacy, and adverse effects as a topical hemostat

DF Thompson, NA Letassy, and GD Thompson

Fibrin glue is composed of two separate solutions of fibrinogen and thrombin. When mixed together, these agents mimic the last stages of the clotting cascade to form a fibrin clot. Fibrin glue is available in Europe but is not commercially available in the U.S.; therefore, investigators have extemporaneously compounded their own fibrin glue. Fibrinogen can be obtained from pooled, single-donor, and autologous blood donors and is usually isolated by the process of cryoprecipitation. The thrombin component is generally derived from commercial bovine sources. Some investigators have added calcium chloride and/or antifibrinolytics (i.e., aminocaproic acid, aprotinin) to their preparations. Fibrin glue can be applied using a double-barrel syringe or by spray application. Although fibrin glue has been used in a variety of surgical procedures, it has been especially useful in heparinized patients undergoing cardiovascular procedures requiring extracorporeal circulation, as it does not require an intact hemostatic system to be effective. Fibrin glue also has been evaluated in presealing woven or knitted Dacron vascular grafts. The major drawback to its use is the risk of transmitted serological disease from pooled and single-donor blood donors. The safest preparations use the patient's own blood to prepare fibrin glue. Overall, fibrin glue is a useful adjunct to other methods to control bleeding in selected surgical patients.


This article has been cited by other articles:


Home page
 EuropaceHome page
D. J. Milic, Z. D. Perisic, S. S. Zivic, Z. A. Stanojkovic, A. M. Stojkovic, N. D. Karanovic, N. H. Krstic, and S. S. Salinger
Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment
Europace, January 1, 2005; 7(4): 374 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D.-G. Lee, H.-S. Chun, D.-S. Yim, S.-M. Choi, J.-H. Choi, J.-H. Yoo, W.-S. Shin, and M.-W. Kang
Efficacies of Vancomycin, Arbekacin, and Gentamicin Alone or in Combination against Methicillin-Resistant Staphylococcus aureus in an In Vitro Infective Endocarditis Model
Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3768 - 3773.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. R. Baumann, J. L. Ulmer, P. G. Ambrose, M. J. Garvey, and D. T. Jones
Closure of a Bronchopleural Fistula Using Decalcified Human Spongiosa and a Fibrin Sealant
Ann. Thorac. Surg., July 1, 1997; 64(1): 230 - 233.
[Abstract] [Full Text]


homecopy help contact us subscription past issues search current issue
Copyright © 1988 by Harvey Whitney Books Company.